CacheBy

Dimabio 제품 카탈로그

총 6,861개 제품 중 401–500번째 · 5 / 69 쪽. 파트넘버 순입니다. 제품을 열면 사양과 함께 재고·가격·납기를 문의할 수 있습니다.

  1. BME100147BBiotinylated Anti-GPC3(Hu9F2) mAb
  2. BME100147PPE-conjugated Anti-GPC3(Hu9F2) mAb
  3. BME100148Anti-OSMR(vixarelimab biosimilar) mAb
  4. BME100148BBiotinylated Anti-OSMR(vixarelimab biosimilar) mAb
  5. BME100148PPE-conjugated Anti-OSMR(vixarelimab biosimilar) mAb
  6. BME100149Anti-HTRA1(galegenimab biosimilar) mAb
  7. BME100149BBiotinylated Anti-HTRA1(galegenimab biosimilar) mAb
  8. BME100149PPE-conjugated Anti-HTRA1(galegenimab biosimilar) mAb
  9. BME100150Anti-GP6(glenzocimab biosimilar) mAb
  10. BME100150BBiotinylated Anti-GP6(glenzocimab biosimilar) mAb
  11. BME100150PPE-conjugated Anti-GP6(glenzocimab biosimilar) mAb
  12. BME100151Anti-ENPP3(XENP28278) mAb
  13. BME100151BBiotinylated Anti-ENPP3(Xencor) mAb
  14. BME100151PPE-conjugated Anti-ENPP3(XENP28278) mAb
  15. BME100153Anti-PDL1 (durvalumab biosimilar) mAb
  16. BME100153BBiotinylated Anti-PDL1 (durvalumab biosimilar) mAb
  17. BME100153PPE-conjugated Anti-PDL1 (durvalumab biosimilar) mAb
  18. BME100155Anti-CLEC4C (litifilimab biosimilar) mAb
  19. BME100155BBiotinylated Anti-CLEC4C (litifilimab biosimilar) mAb
  20. BME100155PPE-conjugated Anti-CLEC4C (litifilimab biosimilar) mAb
  21. BME100156Anti-CD45 (apamistamab biosimilar) mAb
  22. BME100156BBiotinylated Anti-CD45 (apamistamab biosimilar) mAb
  23. BME100156PPE-conjugated Anti-CD45 (apamistamab biosimilar) mAb
  24. BME100157Anti-5T4 (H8 biosimilar) mAb
  25. BME100157BBiotinylated Anti-5T4 (H8 biosimilar) mAb
  26. BME100157PPE-conjugated Anti-5T4 (H8 biosimilar) mAb
  27. BME100158Anti-5T4 (GEN-1044 biosimilar) mAb
  28. BME100158BBiotinylated Anti-5T4 (GEN-1044 biosimilar) mAb
  29. BME100158PPE-conjugated Anti-5T4 (GEN-1044 biosimilar) mAb
  30. BME100159Anti-TM4SF1 (AGX101 biosimilar) mAb
  31. BME100159BBiotinylated Anti-TM4SF1 (AGX101 biosimilar) mAb
  32. BME100159PPE-conjugated Anti-TM4SF1 (AGX101 biosimilar) mAb
  33. BME100160Anti-CD20 (obinutuzumab biosimilar) mAb
  34. BME100160BBiotinylated Anti-CD20 (obinutuzumab biosimilar) mAb
  35. BME100160PPE-conjugated Anti-CD20 (obinutuzumab biosimilar) mAb
  36. BME100162Anti-KLRG1(ulviprubart biosimilar) mAb
  37. BME100162BBiotinylated Anti-KLRG1(ulviprubart biosimilar) mAb
  38. BME100162PPE-conjugated Anti-KLRG1(ulviprubart biosimilar) mAb
  39. BME100163Anti-FOLR1(farletuzumab biosimilar) mAb
  40. BME100163BBiotinylated Anti-FOLR1(farletuzumab biosimilar) mAb
  41. BME100163PPE-conjugated Anti-FOLR1(farletuzumab biosimilar) mAb
  42. BME100164Anti-IL23A(guselkumab biosimilar) mAb
  43. BME100164BBiotinylated Anti-IL23A(guselkumab biosimilar) mAb
  44. BME100165Anti-Mesothelin VHH-human IgG1 Fc
  45. BME100165BBiotinylated Anti-Mesothelin VHH-human IgG1 Fc
  46. BME100165PPE-conjugated Anti-Mesothelin VHH-human IgG1 Fc
  47. BME100166Anti-CGRPR(Erenumab biosimilar) mAb
  48. BME100166BBiotinylated Anti-CGRPR(Erenumab biosimilar) mAb
  49. BME100166PPE-conjugated Anti-CGRPR(Erenumab biosimilar) mAb
  50. BME100167Anti-ALPP(TCRCure A06 Biosimilar) mAb
  51. BME100167BBiotinylated Anti-ALPP(TCRCure A06 Biosimilar) mAb
  52. BME100167PPE-conjugated Anti-ALPP(TCRCure A06 Biosimilar) mAb
  53. BME100168Anti-CD70 (Chongqing Precision biosimilar) mAb
  54. BME100168BBiotinylated Anti-CD70 (Chongqing Precision biosimilar) mAb
  55. BME100168PPE-conjugated Anti-CD70 (Chongqing Precision biosimilar) mAb
  56. BME100169Anti-ROR2(ozuriftamab biosimilar) mAb
  57. BME100169BBiotinylated Anti-ROR2(ozuriftamab biosimilar) mAb
  58. BME100169PPE-conjugated Anti-ROR2(ozuriftamab biosimilar) mAb
  59. BME100170Anti-CD74(milatuzumab biosimilar) mAb
  60. BME100170BBiotinylated Anti-CD74(milatuzumab biosimilar) mAb
  61. BME100170PPE-conjugated Anti-CD74(milatuzumab biosimilar) mAb
  62. BME100171Anti-CD79B(polatuzumab biosimilar) mAb
  63. BME100171BBiotinylated Anti-CD79B(polatuzumab biosimilar) mAb
  64. BME100171PPE-conjugated Anti-CD79B(polatuzumab biosimilar) mAb
  65. BME100172Anti-CD166(praluzatamab biosimilar) mAb
  66. BME100172BBiotinylated Anti-CD166(praluzatamab biosimilar) mAb
  67. BME100172PPE-conjugated Anti-CD166(praluzatamab biosimilar) mAb
  68. BME100173Anti-TIM3(sabatolimab biosimilar) mAb
  69. BME100173BBiotinylated Anti-TIM3(sabatolimab biosimilar) mAb
  70. BME100173PPE-conjugated Anti-TIM3(sabatolimab biosimilar) mAb
  71. BME100174Anti-IGF-1R(teprotumumab biosimilar) mAb
  72. BME100174BBiotinylated Anti-IGF-1R(teprotumumab biosimilar) mAb
  73. BME100174PPE-conjugated Anti-IGF-1R(teprotumumab biosimilar) mAb
  74. BME100175Anti-AXL(mecbotamab biosimilar) mAb
  75. BME100175BBiotinylated Anti-AXL(mecbotamab biosimilar) mAb
  76. BME100175PPE-conjugated Anti-AXL(mecbotamab biosimilar) mAb
  77. BME100176Anti-CD93(biosimilar) mAb
  78. BME100176BBiotinylated Anti-CD93(biosimilar) mAb
  79. BME100176PPE-conjugated Anti-CD93(biosimilar) mAb
  80. BME100177Anti-CGRP(Eptinezumab biosimilar) mAb
  81. BME100178Anti-FOLR1(mirvetuximab biosimilar) mAb
  82. BME100178BBiotinylated Anti-FOLR1(mirvetuximab biosimilar) mAb
  83. BME100178PPE-conjugated Anti-FOLR1(mirvetuximab biosimilar) mAb
  84. BME100179Anti-TNFa(golimumab biosimilar) mAb
  85. BME100179BBiotinylated Anti-TNFa(golimumab biosimilar) mAb
  86. BME100179PPE-conjugated Anti-TNFa(golimumab biosimilar) mAb
  87. BME100180Anti-GUCY2C (ICTCAR-CRC) mAb
  88. BME100180BBiotinylated Anti-GUCY2C (ICTCAR-CRC) mAb
  89. BME100180PPE-conjugated Anti-GUCY2C (ICTCAR-CRC) mAb
  90. BME100181Anti-B7-H3 (TAA06 biosimilar) mAb
  91. BME100181BBiotinylated Anti-B7-H3 (TAA06 biosimilar) mAb
  92. BME100181PPE-conjugated Anti-B7-H3 (TAA06 biosimilar) mAb
  93. BME100182Anti-CEACAM5 (Chongqing Precision biosimilar) mAb
  94. BME100182BBiotinylated Anti-CEACAM5 (Chongqing Precision biosimilar) mAb
  95. BME100182PPE-conjugated Anti-CEACAM5 (Chongqing Precision biosimilar) mAb
  96. BME100183Anti-TNFa(Certolizumab biosimilar) mAb
  97. BME100183BBiotinylated Anti-TNFa(Certolizumab biosimilar) mAb
  98. BME100183PPE-conjugated Anti-TNFa(Certolizumab biosimilar) mAb
  99. BME100184Anti-EPCAM(oportuzumab biosimilar) mAb
  100. BME100184BBiotinylated Anti-EPCAM(oportuzumab biosimilar) mAb